Literature DB >> 28526279

An emerging role for mitochondrial dynamics in schizophrenia.

Kyle H Flippo1, Stefan Strack2.   

Abstract

Abnormal brain development has long been thought to contribute to the pathophysiology of schizophrenia. Impaired dendritic arborization, synaptogenesis, and long term potentiation and memory have been demonstrated in animal models of schizophrenia. In addition to aberrant nervous system development, altered brain metabolism and mitochondrial function has long been observed in schizophrenic patients. Single nucleotide polymorphisms in the mitochondrial genome as well as impaired mitochondrial function have both been associated with increased risk for developing schizophrenia. Mitochondrial function in neurons is highly dependent on fission, fusion, and transport of the organelle, collectively referred to as mitochondrial dynamics. Indeed, there is mounting evidence that mitochondrial dynamics strongly influences neuron development and synaptic transmission. While there are a few studies describing altered mitochondrial shape in schizophrenic patients, as well as in animal and in vitro models of schizophrenia, the precise role of mitochondrial dynamics in the pathophysiology of schizophrenia is all but unexplored. Here we discuss the influence of mitochondrial dynamics and mitochondrial function on nervous system development, and highlight recent work suggesting a link between aberrant mitochondrial dynamics and schizophrenia.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Axonal transport; Bioenergetics; Mitochondria; Mitochondrial dynamics; Mitochondrial fission; Mitochondrial fusion

Mesh:

Year:  2017        PMID: 28526279      PMCID: PMC5646380          DOI: 10.1016/j.schres.2017.05.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  108 in total

1.  Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.

Authors:  I Maurer; S Zierz; H Möller
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

Review 3.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

4.  A lethal defect of mitochondrial and peroxisomal fission.

Authors:  Hans R Waterham; Janet Koster; Carlo W T van Roermund; Petra A W Mooyer; Ronald J A Wanders; James V Leonard
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

5.  KIF5A mutations cause an infantile onset phenotype including severe myoclonus with evidence of mitochondrial dysfunction.

Authors:  Jessica Duis; Shannon Dean; Carolyn Applegate; Amy Harper; Rui Xiao; Weimin He; James D Dollar; Lisa R Sun; Marta Biderman Waberski; Thomas O Crawford; Ada Hamosh; Carl E Stafstrom
Journal:  Ann Neurol       Date:  2016-08-24       Impact factor: 10.422

Review 6.  DISC1 is a coordinator of intracellular trafficking to shape neuronal development and connectivity.

Authors:  M J Devine; R Norkett; J T Kittler
Journal:  J Physiol       Date:  2016-06-12       Impact factor: 5.182

Review 7.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

8.  A Disc1 mutation differentially affects neurites and spines in hippocampal and cortical neurons.

Authors:  A M Lepagnol-Bestel; M Kvajo; M Karayiorgou; M Simonneau; J A Gogos
Journal:  Mol Cell Neurosci       Date:  2013-02-06       Impact factor: 4.314

Review 9.  Mechanisms of neuronal homeostasis: Autophagy in the axon.

Authors:  Sandra Maday
Journal:  Brain Res       Date:  2016-03-30       Impact factor: 3.252

10.  The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice.

Authors:  Junko Wakabayashi; Zhongyan Zhang; Nobunao Wakabayashi; Yasushi Tamura; Masahiro Fukaya; Thomas W Kensler; Miho Iijima; Hiromi Sesaki
Journal:  J Cell Biol       Date:  2009-09-14       Impact factor: 10.539

View more
  26 in total

1.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

2.  AKAP1 Protects from Cerebral Ischemic Stroke by Inhibiting Drp1-Dependent Mitochondrial Fission.

Authors:  Kyle H Flippo; Aswini Gnanasekaran; Guy A Perkins; Ahmad Ajmal; Ronald A Merrill; Audrey S Dickey; Susan S Taylor; G Stanley McKnight; Anil K Chauhan; Yuriy M Usachev; Stefan Strack
Journal:  J Neurosci       Date:  2018-08-09       Impact factor: 6.167

Review 3.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

4.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

5.  Synaptic Proteome Alterations in the Primary Auditory Cortex of Individuals With Schizophrenia.

Authors:  Matthew L MacDonald; Megan Garver; Jason Newman; Zhe Sun; Joseph Kannarkat; Ryan Salisbury; Jill Glausier; Ying Ding; David A Lewis; Nathan Yates; Robert A Sweet
Journal:  JAMA Psychiatry       Date:  2020-01-01       Impact factor: 21.596

6.  Independent Methylome-Wide Association Studies of Schizophrenia Detect Consistent Case-Control Differences.

Authors:  Robin F Chan; Andrey A Shabalin; Carolina Montano; Eilis Hannon; Christina M Hultman; Margaret D Fallin; Andrew P Feinberg; Jonathan Mill; Edwin J C G van den Oord; Karolina A Aberg
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

Review 7.  ROS as Regulators of Mitochondrial Dynamics in Neurons.

Authors:  Carolina Cid-Castro; Diego Rolando Hernández-Espinosa; Julio Morán
Journal:  Cell Mol Neurobiol       Date:  2018-04-23       Impact factor: 5.046

Review 8.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

9.  Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia.

Authors:  Annie Kathuria; Kara Lopez-Lengowski; Smita S Jagtap; Donna McPhie; Roy H Perlis; Bruce M Cohen; Rakesh Karmacharya
Journal:  JAMA Psychiatry       Date:  2020-07-01       Impact factor: 21.596

Review 10.  Carnosic Acid as a Promising Agent in Protecting Mitochondria of Brain Cells.

Authors:  Marcos Roberto de Oliveira
Journal:  Mol Neurobiol       Date:  2018-01-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.